FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200372293> ?p ?o ?g. }

• W4200372293 endingPage "586" @default.
• W4200372293 startingPage "574" @default.
• W4200372293 abstract "A series of recombinant human type 5 adenoviruses that express the full-length or membrane-truncated spike protein (S) of SARS-CoV-2 (AdCoV2-S or AdCoV2-SdTM, respectively) was tested the efficacy against SARS-CoV-2 via intranasal (i.n.) or subcutaneous (s.c.) immunization in a rodent model. Mucosal delivery of adenovirus (Ad) vaccines could induce anti-SARS-CoV-2 IgG and IgA in the serum and in the mucosal, respectively as indicated by vaginal wash (vw) and bronchoalveolar lavage fluid (BALF). Serum anti-SARS-CoV-2 IgG but not IgA in the vw and BALF was induced by AdCoV2-S s.c.. Administration of AdCoV2-S i.n. was able to induce higher anti-SARS-CoV-2 binding and neutralizing antibody levels than s.c. injection. AdCoV2-SdTM i.n. induced a lower antibody responses than AdCoV2-S i.n.. Induced anti-S antibody responses by AdCoV2-S via i.n. or s.c. were not influenced by the pre-existing serum anti-Ad antibody. Novelty, S-specific IgG1 which represented Th2-mediated humoral response was dominantly induced in Ad i.n.-immunized serum in contrast to more IgG2a which represented Th1-mediated cellular response found in Ad s.c.-immunized serum. The activation of S-specific IFN-ɣ and IL-4 in splenic Th1 and Th2 cells, respectively, was observed in the AdCoV2-S i.n. and s.c. groups, indicating the Th1 and Th2 immunity were activated. AdCoV2-S and AdCoV2-SdTM significantly prevented body weight loss and reduced pulmonary viral loads in hamsters. A reduction in inflammation in the lungs was observed in AdCoV-S via i.n. or s.c.-immunized hamsters following a SARS-CoV-2 challenge. It correlated to Th1 cytokine but no inflammatory cytokines secretions found in AdCoV-S i.n. -immunized BALF. These results indicate that intranasal delivery of AdCoV2-S vaccines is safe and potent at preventing SARS-CoV-2 infections." @default.
• W4200372293 created "2021-12-31" @default.
• W4200372293 creator A5020503630 @default.
• W4200372293 creator A5030621191 @default.
• W4200372293 creator A5034952432 @default.
• W4200372293 creator A5040898705 @default.
• W4200372293 creator A5058878135 @default.
• W4200372293 creator A5059204874 @default.
• W4200372293 creator A5070648053 @default.
• W4200372293 creator A5078795990 @default.
• W4200372293 date "2022-01-01" @default.
• W4200372293 modified "2023-10-11" @default.
• W4200372293 title "Induction of Th1 and Th2 in the protection against SARS-CoV-2 through mucosal delivery of an adenovirus vaccine expressing an engineered spike protein" @default.
• W4200372293 cites W1600341088 @default.
• W4200372293 cites W1601917502 @default.
• W4200372293 cites W1930602663 @default.
• W4200372293 cites W1942668068 @default.
• W4200372293 cites W1974107455 @default.
• W4200372293 cites W1977011552 @default.
• W4200372293 cites W1983304157 @default.
• W4200372293 cites W2001449446 @default.
• W4200372293 cites W2017987372 @default.
• W4200372293 cites W2022294540 @default.
• W4200372293 cites W2029836713 @default.
• W4200372293 cites W2035269438 @default.
• W4200372293 cites W2040073701 @default.
• W4200372293 cites W2054258731 @default.
• W4200372293 cites W2055394761 @default.
• W4200372293 cites W2065855042 @default.
• W4200372293 cites W2067174610 @default.
• W4200372293 cites W2077915163 @default.
• W4200372293 cites W2095633747 @default.
• W4200372293 cites W2096428863 @default.
• W4200372293 cites W2134342374 @default.
• W4200372293 cites W2143242765 @default.
• W4200372293 cites W2152349977 @default.
• W4200372293 cites W2155657105 @default.
• W4200372293 cites W2156487862 @default.
• W4200372293 cites W2175077154 @default.
• W4200372293 cites W2289111537 @default.
• W4200372293 cites W2292700442 @default.
• W4200372293 cites W2308902669 @default.
• W4200372293 cites W2361714888 @default.
• W4200372293 cites W2513547424 @default.
• W4200372293 cites W2573032076 @default.
• W4200372293 cites W2825912598 @default.
• W4200372293 cites W2917849476 @default.
• W4200372293 cites W3009335299 @default.
• W4200372293 cites W3013843415 @default.
• W4200372293 cites W3027138240 @default.
• W4200372293 cites W3036409928 @default.
• W4200372293 cites W3036887118 @default.
• W4200372293 cites W3049654234 @default.
• W4200372293 cites W3080761414 @default.
• W4200372293 cites W3080936612 @default.
• W4200372293 cites W3083773456 @default.
• W4200372293 cites W3091814234 @default.
• W4200372293 cites W3093038587 @default.
• W4200372293 cites W3111255098 @default.
• W4200372293 cites W3112389805 @default.
• W4200372293 cites W3116163512 @default.
• W4200372293 cites W3138437538 @default.
• W4200372293 cites W3145792142 @default.
• W4200372293 cites W3186329587 @default.
• W4200372293 cites W3187526644 @default.
• W4200372293 cites W4205483821 @default.
• W4200372293 cites W4206708282 @default.
• W4200372293 cites W4246504300 @default.
• W4200372293 doi "https://doi.org/10.1016/j.vaccine.2021.12.024" @default.
• W4200372293 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34952759" @default.
• W4200372293 hasPublicationYear "2022" @default.
• W4200372293 type Work @default.
• W4200372293 citedByCount "11" @default.
• W4200372293 countsByYear W42003722932022 @default.
• W4200372293 countsByYear W42003722932023 @default.
• W4200372293 crossrefType "journal-article" @default.
• W4200372293 hasAuthorship W4200372293A5020503630 @default.
• W4200372293 hasAuthorship W4200372293A5030621191 @default.
• W4200372293 hasAuthorship W4200372293A5034952432 @default.
• W4200372293 hasAuthorship W4200372293A5040898705 @default.
• W4200372293 hasAuthorship W4200372293A5058878135 @default.
• W4200372293 hasAuthorship W4200372293A5059204874 @default.
• W4200372293 hasAuthorship W4200372293A5070648053 @default.
• W4200372293 hasAuthorship W4200372293A5078795990 @default.
• W4200372293 hasBestOaLocation W42003722932 @default.
• W4200372293 hasConcept C104317684 @default.
• W4200372293 hasConcept C126322002 @default.
• W4200372293 hasConcept C14086860 @default.
• W4200372293 hasConcept C159047783 @default.
• W4200372293 hasConcept C159654299 @default.
• W4200372293 hasConcept C203014093 @default.
• W4200372293 hasConcept C2776548049 @default.
• W4200372293 hasConcept C2777714996 @default.
• W4200372293 hasConcept C2777961210 @default.
• W4200372293 hasConcept C2779261636 @default.
• W4200372293 hasConcept C2779341262 @default.
• W4200372293 hasConcept C2780801004 @default.
• W4200372293 hasConcept C2780898057 @default.

• next